SCHEMBL16363100

SCHEMBL16363100

COc1ccc(-c2cccc(COc3ccc4c(c3)OC[C@H]4CC(=O)O)c2)cc1

nearest known ligand 0.76

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 20/20 0.76
PPARD Q03181 3/20 0.67
PPARG P37231 2/20 0.67
PPARA Q07869 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16363102 1.00 FFAR1 (0.76) FFAR1PPARDPPARGPPARA
SCHEMBL16363103 0.92 FFAR1 (0.75) FFAR1PPARDPPARGPPARA
SCHEMBL3449823 0.88 FFAR1 (0.85) FFAR1
SCHEMBL16363099 0.87 FFAR1 (0.56) FFAR1
SCHEMBL16363108 0.87 FFAR1 (0.56) FFAR1
SCHEMBL1632685 0.86 FFAR1 (1.00) FFAR1
SCHEMBL16249163 0.85 FFAR1 (0.89) FFAR1
SCHEMBL3450662 0.85 FFAR1 (1.00) FFAR1
SCHEMBL15125767 0.85 FFAR1 (0.89) FFAR1
SCHEMBL3451082 0.84 FFAR1 (0.70) FFAR1PPARDPPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9139548-B2 Polycyclic derivatives, preparation process and pharmaceutical use thereof JIANGSU HENGRUI MEDICINE CO., LTD. (CN) 2015-09-22 US disclosed
US-20150005282-A1 POLYCYCLIC DERIVATIVES, PREPARATION PROCESS AND PHARMACEUTICAL USE THEREOF JIANGSU HENGRUI MEDICINE CO., LTD. (CN) 2015-01-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150005282-A1 POLYCYCLIC DERIVATIVES, PREPARATION PROCESS AND PHARMACEUTICAL USE THEREOF GPR119, GPR55, GPR65 FFAR1 19/4885PPARD 16/4885PPARG 18/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.